| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |